Orlucent® Achieves ISO 13485 Certification

International Organization for Standardization Awarded to Maker of Fluorescent Molecular Imaging Test for Suspicious Nevi

Los Gatos, CA, December 9, 2020 – Orlucent, Inc. has received International Organization for Standardization (ISO) certification, effective through 2023. This certification is a highly desired and recognized certification for medical device manufacturers. It helps to establish a company’s credibility among suppliers, customers, shareholders, and institutions by demonstrating the company’s commitment to quality and that its Quality Management System is compliant with established and recognized industry standards.

Orlucent advanced skin cancer detection and molecular imaging technology